VANCOUVER and SAN DIEGO, Oct. 31 /CNW/ - MIGENIX Inc. (TSX: MGI; OTC:
MGIFF), a clinical-stage developer of drugs for infectious diseases will
present at the Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference
being held at the New York Palace Hotel in New York, NY on November 5-7, 2007.
Jim DeMesa, M.D., President & CEO is scheduled to present on Monday, November
5 at 4:45 p.m. EST in the Holmes I room.
